143 related articles for article (PubMed ID: 32534492)
1. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes.
Amit M; Bell D; Hunt PJ; Hanna E; Su SY; Kupferman M; Aashiq M; Takahashi H; Gidley PW; Nader ME; DeMonte F; Raza SM
J Neurosurg; 2020 Jun; 134(5):1392-1398. PubMed ID: 32534492
[TBL] [Abstract][Full Text] [Related]
2. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management.
Raza SM; Ramakrishna R; Weber RS; Kupferman ME; Gidley PW; Hanna EY; DeMonte F
J Neurosurg; 2015 Sep; 123(3):781-8. PubMed ID: 25909577
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in pterygopalatine and infratemporal fossa malignant tumours: A single institution experience.
He Y; Yang H; Sun J; Zhang C; Zhu H; Liu Z
J Craniomaxillofac Surg; 2015 May; 43(4):537-44. PubMed ID: 25819099
[TBL] [Abstract][Full Text] [Related]
4. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.
Ganly I; Patel SG; Singh B; Kraus DH; Bridger PG; Cantu G; Cheesman A; De Sa G; Donald P; Fliss DM; Gullane P; Janecka I; Kamata SE; Kowalski LP; Levine PA; Medina dos Santos LR; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):73-8. PubMed ID: 16415433
[TBL] [Abstract][Full Text] [Related]
5. Surgical approaches for infratemporal fossa tumor resection: Fifteen years' experience of a single center.
Yafit D; Duek I; Abu-Ghanem S; Ungar OJ; Wengier A; Moshe-Levyn H; Yanko-Arzi R; Zaretski A; Margalit N; Abergel A; Muhanna N; Fliss DM
Head Neck; 2019 Nov; 41(11):3755-3763. PubMed ID: 31407445
[TBL] [Abstract][Full Text] [Related]
6. Malignant tumors of the anterolateral skull base.
Hentschel SJ; Vora Y; Suki D; Hanna EY; DeMonte F
Neurosurgery; 2010 Jan; 66(1):102-12; discussion 112. PubMed ID: 20023541
[TBL] [Abstract][Full Text] [Related]
7. An Osseous Destructive Mass of the Infratemporal Fossa.
Vesole AS; Shibata SB; Hansen MR
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):194-195. PubMed ID: 31774471
[No Abstract] [Full Text] [Related]
8. Chondrosarcoma of the skull base: long-term follow-up.
Brackmann DE; Teufert KB
Otol Neurotol; 2006 Oct; 27(7):981-91. PubMed ID: 17006349
[TBL] [Abstract][Full Text] [Related]
9. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies.
Hunt PJ; Amit M; Kabotyanski KE; Aashiq M; Hanna EY; Kupferman ME; Su SY; Gidley PW; Nader ME; DeMonte F; Raza SM
Neurosurg Rev; 2023 Jun; 46(1):157. PubMed ID: 37386212
[TBL] [Abstract][Full Text] [Related]
10. Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse.
Raza SM; Habib A; Wang WL; Gildey PW; Conley AP; Nader ME; Hanna EY; Su SY; DeMonte F
Neurosurgery; 2020 Jan; 86(1):E23-E32. PubMed ID: 31515560
[TBL] [Abstract][Full Text] [Related]
11. Craniofacial resection for cranial base malignancies involving the infratemporal fossa.
Bilsky MH; Bentz B; Vitaz T; Shah J; Kraus D
Neurosurgery; 2005 Oct; 57(4 Suppl):339-47; discussion 339-47. PubMed ID: 16234683
[TBL] [Abstract][Full Text] [Related]
12. Infratemporal fossa surgical approaches to primary/recurrent malignancies of salivary origin: paradigm surgical shift, patient selection, and oncologic outcomes.
Bradley PJ
Curr Opin Otolaryngol Head Neck Surg; 2020 Apr; 28(2):79-89. PubMed ID: 32011396
[TBL] [Abstract][Full Text] [Related]
13. Anterolateral and lateral skull-base approaches for treatment of neoplastic diseases.
Carrillo JF; Rivas Leon B; Celis MA; Ponce-de-Leon S; Ochoa-Carrillo FJ
Am J Otolaryngol; 2004; 25(1):58-67. PubMed ID: 15011208
[TBL] [Abstract][Full Text] [Related]
14. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
15. Successful management of recurrent adenoid cystic carcinoma in the deep infratemporal fossa by maxillo-orbito-zygomatic approach.
Hongo T; Fukushima J; Uchida Y; Rikimaru F; Toh S; Higaki Y; Masuda M
Auris Nasus Larynx; 2019 Dec; 46(6):921-926. PubMed ID: 30626547
[TBL] [Abstract][Full Text] [Related]
16. Extended Middle Cranial Fossa Approach for Lesions Invading Infratemporal Fossa: Anatomic Study and Clinical Application.
Mastronardi L; Corrivetti F; Scavo CG; Cacciotti G; Roperto R; Sufianov A; De Waele L; Fukushima T
World Neurosurg; 2020 Jun; 138():83. PubMed ID: 32145415
[TBL] [Abstract][Full Text] [Related]
17. Skull base chondrosarcomas: surgical treatment and results.
Sbaihat A; Bacciu A; Pasanisi E; Sanna M
Ann Otol Rhinol Laryngol; 2013 Dec; 122(12):763-70. PubMed ID: 24592579
[TBL] [Abstract][Full Text] [Related]
18. Surgical strategy for tumors located in or extending from the intracranial space to the infratemporal fossa-Advantages of the transcranial approach (zygomatic infratemporal fossa approach) and the indications for a combined transcranial and transcervical approach-.
Yoshida K; Kawase T; Tomita T; Ogawa K; Kawana H; Yago K; Asanami S
Neurol Med Chir (Tokyo); 2009 Dec; 49(12):580-6. PubMed ID: 20035132
[TBL] [Abstract][Full Text] [Related]
19. [Application of computer-aided design and navigation technology in skull base and infratemporal fossa tumor surgery].
Guo YX; Peng X; Liu XJ; Zhang L; Yu GY; Guo CB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Nov; 48(11):645-7. PubMed ID: 24513067
[TBL] [Abstract][Full Text] [Related]
20. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach.
Ramakrishna R; Raza SM; Kupferman M; Hanna E; DeMonte F
J Neurosurg; 2016 Jan; 124(1):115-21. PubMed ID: 26252456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
